cov Kev txheeb ze zog (RS) Rating rau BioCryst Cov Tshuaj Kho Mob (BCRX) Tshuag tau nce mus rau qhov feem pua ntawm hnub Friday tshiab, nrog nce ntawm 64 txog 84.
X
Thaum saib cov cov khoom lag luam zoo tshaj plaws los yuav thiab saib, ib qho tseem ceeb los saib ze yog tus nqi zog.
IBD qhov tshwj xeeb RS Rating txheeb xyuas qhov kev ua tau zoo los ntawm kev siv 1 (qhov phem tshaj) rau 99 (zoo tshaj) cov qhab nia uas qhia tau hais tias qhov kev ua tau zoo ntawm cov nqi hauv 52 lub lis piam dhau los sib tw rau lwm lub khw.
Keeb kwm qhia tau hais tias cov khoom lag luam ua tau zoo tshaj plaws feem ntau muaj RS Rating tsawg kawg yog 80 thaum lawv pib lawv qhov nce siab tshaj plaws.
Saib seb IBD Yuav Pab Nyiaj Koj Li Nyiaj Tau Li Cas Ntxiv Nyob Hauv Tshuag
Puas yog BioCryst Pharmaceuticals Tshuag Kev Yuav?
BioCryst Pharm Tshuag tau sim ua kom tiav kev sib koom ua ke nrog 15.53 muas point. Cov khoom lag luam biotech tsis ntev los no tau rov ua nws txoj kab 200-hnub tsiv. Saib seb cov khoom lag luam puas tuaj yeem tshem tawm tus nqi tawg hauv cov ntim hnyav. Nyeem “Nrhiav Rau Cov Tom Qab Loj Cov Khoom Lag Luam Loj Tshaj? Pib Nrog 3 Kauj Ruam No"rau cov lus qhia ntxiv.
Lub tuam txhab biotech tau tshaj tawm 0% cov nyiaj tau los loj hlob hauv peb lub hlis dhau los. Cov nyiaj tau los tau los ntawm 85%.
BioCryst Pharmaceuticals khwv tau 122 qib ntawm nws cov phooj ywg hauv pab pawg kho mob-Biomed/Biotech kev lag luam. Genmab ADR (GMAB) thiab Harmony Biosciences (HRMY) kuj yog cov pab pawg neeg cov khoom lag luam siab tshaj plaws. Yog xav paub ntxiv txog kev lag luam xov xwm, mus saib "Biotech Thiab Pharmaceutical Industry And Stock News. "
KOJ UA LI CAS:
Cov cuab yeej MarketSmith tuaj yeem Pab Tus Kheej Cov Lag Luam
Live IBD: Ib qho Cuab Yeej Tshiab rau Kev Tshawb Xyuas Kev Lag Luam Txhua Hnub
Tau Nyiaj Los Ntawm Txij Lub Sij Hawm Luv Nrog SwingTrader
Tau qhov twg los: https://www.investors.com/news/technology/biocryst-pharmaceuticals-stock-sees-rs-rating-rise-to-84/?src=A00220&yptr=yahoo